NASDAQ:ONCT

Oncternal Therapeutics (ONCT) Price Target & Analyst Ratings

$0.32

+0.02 (+6.63%)

(As of 06/9/2023 ET)

Compare

Today's Range: $0.31
▼
$0.37
50-Day Range: $0.28
▼
$0.79
52-Week Range: $0.26
▼
$1.41

Volume: 489,575 shs
Average Volume: 408,838 shs
Market Capitalization: $18.89 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $5.77

Oncternal Therapeutics Consensus Rating and Price Target (2023)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Hold
Based on 6 Analyst Ratings

Consensus Analyst Price Target

$5.77
1,693.12% Upside

High Prediction	$9.00
Average Prediction	$5.77
Low Prediction	$1.30

Type	Current 6/9/22 to 6/9/23	1 Month Ago 5/10/22 to 5/10/23	3 Months Ago 3/11/22 to 3/11/23	1 Year Ago 6/9/21 to 6/9/22
Consensus Rating	Hold	Hold	Buy	Buy
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	0 Buy rating(s)	0 Buy rating(s)	4 Buy rating(s)	3 Buy rating(s)
Hold	6 Hold rating(s)	6 Hold rating(s)	0 Hold rating(s)	0 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$5.77	$5.77	$5.50	$7.00
Predicted Upside	1,693.12% Upside	701.26% Upside	458.38% Upside	147.35% Upside

Get Oncternal Therapeutics Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for ONCT and its competitors with MarketBeat's FREE daily newsletter.

ONCT Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

ONCT Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Oncternal Therapeutics Stock vs. The Competition

Type	Oncternal Therapeutics	Medical Companies	S&P 500
Consensus Rating Score	2.00	2.66	2.48
Consensus Rating	Hold	Buy	Hold
Predicted Upside	1,693.12% Upside	1,156.63% Upside	247.61% Upside
News Sentiment Rating	Neutral News	Positive News	Positive News

Historical Target Prices and Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating
4/6/2023	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	L. Watsek Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Overweight ➝ Neutral
4/4/2023	Brookline Capital Acquisition Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Buy ➝ Hold
4/4/2023	Maxim Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Buy ➝ Hold
4/4/2023	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	R. Selvaraju Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Buy ➝ Neutral
4/4/2023	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Outperform ➝ Market Perform
4/3/2023	Brookline Capital Management Subscribe to MarketBeat All Access for the recommendation accuracy rating	K. Dolliver Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Buy ➝ Hold

(Data available from 6/9/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)

ONCT Price Target - Frequently Asked Questions

What is Oncternal Therapeutics's consensus rating and price target?: According to the issued ratings of 6 analysts in the last year, the consensus rating for Oncternal Therapeutics stock is Hold based on the current 6 hold ratings for ONCT. The average twelve-month price prediction for Oncternal Therapeutics is $5.77 with a high price target of $9.00 and a low price target of $1.30. Learn more on ONCT's analyst rating history.
Do Wall Street analysts like Oncternal Therapeutics more than its competitors?: Analysts like Oncternal Therapeutics less than other Medical companies. The consensus rating for Oncternal Therapeutics is Hold while the average consensus rating for medical companies is Buy. Learn more on how ONCT compares to other companies.
Is Oncternal Therapeutics being downgraded by Wall Street analysts?: Over the previous 90 days, Oncternal Therapeutics's stock had 5 downgrades by analysts.

Does Oncternal Therapeutics's stock price have much upside?: According to analysts, Oncternal Therapeutics's stock has a predicted upside of 701.26% based on their 12-month price targets.
What analysts cover Oncternal Therapeutics?: Oncternal Therapeutics has been rated by Brookline Capital Acquisition, Brookline Capital Management, Cantor Fitzgerald, HC Wainwright, Maxim Group, and Oppenheimer in the past 90 days.

Stock Ratings Reports and Tools

Related Companies:

Today's Ratings:

Top Rated Stocks:

More Ratings Tools:

This page (NASDAQ:ONCT) was last updated on 6/9/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial